110. Secret Sauce for Effective Vaccines: Adjuvants and Effective Immune Responses
Friday, October 5, 2018: 8:45 AM-10:00 AM
Room: W 2014-2016

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the mechanism of adjuvants
  • explain the risks and benefits of adjuvants
  • list which adjuvants are currently in use or will be used soon

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, HIV clinicians, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Medical students and residents, Members-in-training, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists, Vaccinologists

Tracks: Trainee, Pediatric ID, Adult ID, Investigative ID

Moderator:  H. Keipp Talbot, MD, MPH, Vanderbilt University Medical Center

8:45 AM
What Are Adjuvants?
Alan Cross, MD

9:10 AM
Currently Used Adjuvants
Nathalie Garcon, PharmD, PhD

9:35 AM
Future Adjuvants
Christopher Fox, PhD

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-225-L04-P


H. K. Talbot, Sanofi Pasteur: Investigator , Research grant . Gilead: Investigator , Research grant . MedImmune: Investigator , Research grant . Vaxinnate: Safety Board , none . Seqirus: Safety Board , none .

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.